These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20309391)

  • 21. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy.
    Lopes LR; Brito D; Belo A; Cardim N;
    Int J Cardiol; 2019 Mar; 278():173-179. PubMed ID: 30554928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Wang J; Xu SJ; Zhou H; Wang LJ; Hu B; Fang F; Zhang XM; Luo YW; He XY; Zhuang SW; Li XM; Liu ZM; Hu DY
    Clin Cardiol; 2009 Sep; 32(9):E16-21. PubMed ID: 19645038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double heterozygous variant in
    Suzuki T; Saito K; Yoshikawa T; Hirono K; Hata Y; Nishida N; Yasuda K; Nagashima M
    J Cardiol Cases; 2022 Apr; 25(4):213-217. PubMed ID: 35911064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy.
    Rafael JF; Cruz FEDS; Carvalho ACC; Gottlieb I; Cazelli JG; Siciliano AP; Dias GM
    Arq Bras Cardiol; 2017 Apr; 108(4):354-360. PubMed ID: 28538763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
    Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variations of beta-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy.
    Rodríguez R; Guerrero D; Rivas Y; Lacruz A; Flores Y
    Invest Clin; 2014 Mar; 55(1):23-31. PubMed ID: 24758099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes.
    Jeschke B; Uhl K; Weist B; Schröder D; Meitinger T; Döhlemann C; Vosberg HP
    Hum Genet; 1998 Mar; 102(3):299-304. PubMed ID: 9544842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
    Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
    BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy.
    O'Donnell K; Adin D; Atkins CE; DeFrancesco T; Keene BW; Tou S; Meurs KM
    Anim Genet; 2021 Aug; 52(4):542-544. PubMed ID: 33970514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
    Brough J; Jain M; Jerves T; Kruszka P; McGuffey E
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
    van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
    Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.